Sutro Biopharma (STRO) Return on Assets [ROA] (2018 - 2026)
Sutro Biopharma's Return on Assets [ROA] was -83.44% in Q2 2026, down 15.57 percentage points from -67.86% a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Sutro Biopharma came in at -68.12%, down 15.08 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -56.44 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -53.03% in FY2024 (-28.70 pp), -24.34% in FY2023 (+7.52 pp), -31.86% in FY2022 (-3.16 pp) and -28.70% in FY2021 (-17.02 pp).
- Quarterly Return on Assets [ROA] has moved between -94.10% (Q4 2025) and -23.14% (Q3 2021) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in 1 of the last seven quarters, with an average year-over-year change of -30.68 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2024 (a gain of 12.12 percentage points); the worst was Q3 2025 (a drop of 61.00 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 2.00% |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | -82.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83.44% |
| Dec 31, 2025 | -94.10% |
| Sep 30, 2025 | -87.35% |
| Jun 30, 2025 | -67.86% |
| Mar 31, 2025 | -66.21% |
| Dec 31, 2024 | -54.23% |
| Sep 30, 2024 | -26.35% |
| Jun 30, 2024 | -27.89% |
| Mar 31, 2024 | -26.30% |
| Dec 31, 2023 | -23.67% |
| Sep 30, 2023 | -38.47% |
| Jun 30, 2023 | -34.67% |
| Mar 31, 2023 | -34.03% |
| Dec 31, 2022 | -29.52% |
| Sep 30, 2022 | -31.22% |
| Jun 30, 2022 | -38.92% |
| Mar 31, 2022 | -35.43% |
| Dec 31, 2021 | -26.61% |
| Sep 30, 2021 | -23.14% |
| Jun 30, 2021 | -18.47% |
API Access
Sutro Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();